NEW YORK (Reuters) – New Jersey health officials have urged more than 3,700 former patients of a surgical facility to get blood tests “out of an abundance of caution,” because they may have been exposed to HIV, hepatitis B and hepatitis C. Although the risk of infection is low, patients who had procedures at the… Read More: New Jersey urges patients at facility to check for HIV… »
Print this page KENILWORTH, N.J.–(BUSINESS WIRE) December 19, 2018 –Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Keytruda, Merck’s anti-PD-1 therapy, for the treatment of adult and pediatric patients with recurrent locally advanced or metastatic Merkel cell carcinoma (MCC), based… Read More: FDA Approves Keytruda (pembrolizumab) for the Treatment of Patients with… »
Nearly half of Medicare patients in long-term care hospitals experienced adverse or temporary harm events during their stays. That’s among the findings of the HHS Office of Inspector General, which conducted a two-stage medical record review using physician reviewers to identify adverse events and temporary harm events in the sampled records. One in five Medicare… Read More: OIG: 46% of Medicare patients in LTC hospitals hit by… »
Smart sock maker Sensoria is teaming up with the Michael J. Fox Foundation and independent research group Neuroscience Research Australia to launch a 100-patient clinical trial looking at what smart textiles in socks can do for Parkinson’s disease patients. The trial, called Standing Tall-PD, is supported by a grant from MJFF. The first part of… Read More: Clinical trial will explore how Sensoria's smart socks can help… »